The purpose of this project is to support a conference to bring together researchers, clinicians, entrepreneurs, and policy makers to review and discuss implications of advances in molecular medicine for the improvement of health and health care. After an update on the findings from the Human Genome Project and related discoveries in human genetics, the six-day conference will turn to half-day sessions on related topics such as: gene therapy for genetic diseases, including which interventions have worked or failed and why; cell therapies for diseases such as cancer, again examining success rates for various technologies to date; issues surrounding embryos and preimplantation diagnosis; genetic approaches to stimulating the immune system (including AIDS therapy); and the application of new techniques to the development of vaccines. Additional topics may include risk identification and behavioral therapy. Each session will begin with a presentation outlining state-of-the-art technology. These presentations will be made by leading scientists who will discuss progress to date, including difficulties yet to be surmounted, and the potential benefits and applications of the new technologies. Each science presentation will be followed by two responders, one of whom will examine the health care impact of the genetics breakthroughs, and one of whom will consider economic, regulatory, public health, and other policy implications. The responders and other conference participants will include clinicians, educators, ethicists, health economists, biotechnology executives, policy makers, funders, and communications professionals.
Amount Awarded $37,500.00
Awarded on: 11/13/1996
Time frame: 12/1/1996 - 11/30/1997
Grant Number: 30194